MBOAT7 and metabolic dysfunction-associated steatotic liver disease: It could be hypothesized that the rs641738 variant leads to a reduced MBOAT7 expression and predisposes to NAFLD/NASH by affecting the acyl remodeling of phosphatidylinositols in the liver, favoring the increase in free arachidonic acid, a potent driver of hepatic inflammation [57,88].